Understanding the prostate—the gland that produces a significant portion of seminal fluid—can help men make informed decisions about screening, recognize warning signs, and appreciate how this organ changes with age. Research from anatomical textbooks and medical institutions consistently describes the prostate as a cone-shaped gland enclosed in a fibrous capsule, measuring approximately the size of a table tennis ball.

This article explains what the prostate is, where it sits in the body, what it does, and how conditions affecting it can impact health. Medical sources including the National Center for Biotechnology Information, SEER Cancer Training, and the Macmillan Cancer Support inform the following overview.

What Is the Prostate Gland?

The prostate gland is a fibromuscular organ belonging exclusively to the male reproductive system. Located in the pelvis, it sits inferior to the bladder and anterior to the rectum, encircling the proximal portion of the urethra. This positioning means the prostate wraps around the tube that carries urine from the bladder out of the body.

Anatomically, the prostate divides into distinct zones. The peripheral zone accounts for roughly 65–70% of the gland’s volume and occupies the posterior surface—this is where most prostate cancers originate. The central zone surrounds the ejaculatory ducts and makes up about 25% of the volume. The transition zone, comprising 5–10% of the gland, surrounds the urethra and is the area where benign prostatic hyperplasia typically develops. The anterior fibromuscular stroma consists primarily of muscle tissue without glandular components.

Five lobes are typically described in anatomical texts: anterior, posterior, two lateral, and one median lobe. The median lobe sits posterior to the urethra and contains the ejaculatory ducts. The prostate contains 10–12 prostatic ducts per side that open directly into the urethra, allowing its secretions to mix with sperm during ejaculation.

Key Insights About the Prostate

• The prostate contributes approximately 30% of the total volume of semen
• The gland commonly enlarges with age, a condition called benign prostatic hyperplasia (BPH)
• Most prostate cancers develop in the peripheral zone, making them accessible during digital rectal examination
• Cancer screening typically combines the prostate-specific antigen (PSA) blood test with a digital rectal exam
• The prostate is not present in women, though analogous glands exist
• Surgical removal of the prostate can affect urinary continence and sexual function

What Are the Functions of the Prostate Gland?

The prostate serves several interconnected functions related to reproduction and, to a lesser extent, urinary control. Its primary role involves secreting an alkaline fluid that constitutes roughly 30% of total semen volume. This fluid enters the reproductive tract through 10–12 prostatic ducts that open into the urethra.

According to anatomical sources, the prostate’s secretions serve multiple purposes. The alkaline nature of the fluid helps neutralize the acidic environment of the female vagina, creating more favorable conditions for sperm survival. The secretions also nourish sperm cells with proteins and enzymes that support their viability and motility. Additionally, the fluid adds volume to semen, which aids in the propulsion of sperm through the female reproductive tract during intercourse.

The Prostate and Ejaculation

The prostate contains smooth muscle tissue that contracts during ejaculation. This muscular component helps propel semen outward through the urethra. The same muscular structure contributes to urinary continence by helping maintain pressure around the urethra, though this function becomes more complex when the prostate enlarges or is surgically removed.

Within the prostate, the two ejaculatory ducts converge at a structure called the seminal colliculus or verumontanum. This is where sperm from the testes and fluid from the seminal vesicles mix with prostate secretions before entering the urethra. The coordination of these processes is essential for normal fertility.

Effects of Prostate Removal

Prostatectomy, performed most commonly to treat prostate cancer, removes the entire gland. Since the prostate surrounds the urethra at the point where it exits the bladder, surgical removal can affect urinary control mechanisms. Potential effects include stress incontinence, particularly in the early recovery period, though many men regain continence over time with pelvic floor exercises.

Erectile dysfunction may occur following prostatectomy due to damage to the neurovascular bundles that run alongside the prostate. These bundles contain nerves essential for achieving and maintaining erections. Nerve-sparing surgical techniques aim to preserve these structures, but not all tumors allow this approach.

Where Is the Prostate Located?

The prostate sits deep within the male pelvis, making it inaccessible from the skin surface. Its anatomical position explains both its clinical significance and why certain examination methods are necessary. Understanding this location helps clarify how healthcare providers examine the gland and why symptoms of prostate enlargement affect urinary function.

Anatomical Relationships

The prostate lies directly below the bladder, with its base oriented toward the bladder neck. The apex points downward toward the pelvic floor muscles. The rectum sits posterior to the prostate, separated only by a layer of fascia called Denonvilliers fascia. This proximity to the rectum is why the digital rectal examination can effectively assess the posterior surface of the prostate.

The pubic symphysis sits anterior to the prostate, separated by retropubic fat and the vesical venous plexus. Laterally, the prostate relates to the levator ani muscle. Inferiorly, it sits just above the external urethral sphincter, which explains why prostate enlargement can affect urinary continence.

Because the prostate wraps around the proximal urethra, changes in its size directly affect how easily urine can flow through that channel. When the transition zone enlarges—as occurs in benign prostatic hyperplasia—the urethra becomes compressed, leading to urinary symptoms such as difficulty starting urination, weak stream, and frequent nighttime urination.

Is There a Prostate in Women?

The prostate gland does not exist in women. Anatomically, the female pelvis lacks a prostate entirely. However, women possess structures that some medical texts refer to as homologous to the prostate. The most significant of these are the Skene glands, also called paraurethral glands.

Skene Glands: The Female Equivalent

The Skene glands sit around the female urethra, in positions roughly analogous to where the prostate sits in males. These glands produce a fluid that contains prostate-specific antigen (PSA) and other substances similar to those found in prostatic secretions. Some medical literature refers to the Skene glands as the “female prostate,” though this term can be misleading.

Unlike the prostate, the Skene glands do not form a single cohesive glandular structure. They consist of multiple small glands scattered around the urethra. They also do not develop the same conditions as the prostate—no cases of “prostate cancer” in women have been documented, though rare cancers can develop in the Skene glands themselves.

The existence of Skene glands explains why some women have measurable PSA levels in their blood, though these levels are typically much lower than those found in men. This presence does not indicate pathology in most cases but is simply a consequence of the homologous glandular tissue.

Embryological Connection

During embryonic development, males and females start with similar tissue structures. The prostate develops from the urogenital sinus under the influence of male hormones. In females, the same tissue gives rise to the Skene glands instead. This explains their similar secretions and their shared ability to produce PSA, though the degree of development differs substantially.

For anyone searching whether women have a prostate, the answer is definitively no. Women have analogous structures, but they are not equivalent to the male prostate and do not carry the same health risks. The misconception may arise from the term “female prostate” appearing occasionally in older or less precise medical literature.

What Is Prostate Cancer?

Prostate cancer develops when cells in the prostate gland grow abnormally and form a tumor. It is one of the most common cancers affecting men, particularly in older age groups. The National Cancer Institute provides comprehensive information about this disease, which ranks among the most frequently diagnosed malignancies in men worldwide.

Most prostate cancers originate in the peripheral zone of the gland, which occupies the posterior surface. This location is fortunate because it makes the gland accessible to digital rectal examination. Cancers developing in this area can often be felt as firm nodules or irregular areas on the surface of the prostate during a physical exam.

Risk Factors and Screening

Age is the most significant risk factor for prostate cancer. The disease rarely occurs before age 50 but becomes increasingly common in men over 65. Family history also plays a role; men with first-degree relatives who had prostate cancer face higher risk. African American men have higher incidence rates and often present with more advanced disease.

Prostate cancer screening typically involves two tests used together. The prostate-specific antigen (PSA) blood test measures levels of this protein, which can become elevated when prostate tissue is abnormal. However, PSA elevation does not mean cancer is present, as benign conditions like prostatitis and benign prostatic hyperplasia also raise PSA levels.

The digital rectal examination (DRE) complements PSA testing by allowing physical assessment of the prostate’s texture and shape. According to TeachMeAnatomy, this examination remains irreplaceable for assessing the peripheral zone, which cannot be reached by any external imaging method with the same effectiveness.

Benign Prostatic Hyperplasia

Not all prostate enlargement indicates cancer. Benign prostatic hyperplasia (BPH) causes non-cancerous growth primarily in the transition zone. This condition is extremely common in older men; by age 60, approximately half of men have some degree of BPH. By age 85, nearly all men show evidence of the condition.

BPH does not increase cancer risk, but its symptoms can significantly affect quality of life. The compression of the urethra by an enlarged transition zone leads to lower urinary tract symptoms including hesitant urination, weak stream, incomplete bladder emptying, and increased urinary frequency, particularly at night.

Treatment options for BPH range from medications that relax prostate smooth muscle or block hormones that stimulate growth to minimally invasive procedures and surgery in more severe cases. The Mayo Clinic provides detailed information about these and related prostate conditions including prostatitis, which involves inflammation or infection of the prostate tissue.

Understanding Prostate Myths and Facts

Despite the prostate being a common topic in health discussions, several misconceptions persist. Distinguishing established facts from myths helps men make better decisions about screening and understand their anatomy more accurately.

Frequently Asked Questions